Bodisen Biotech (LSE:BODI) Change In Receivables : £-1.23 Mil (TTM As of Jun. 2013)

View and export this data going back to . Start your Free Trial

What is Bodisen Biotech Change In Receivables?

Bodisen Biotech's change in receivables for the quarter that ended in Jun. 2013 was £0.26 Mil. It means Bodisen Biotech's Accounts Receivable declined by £0.26 Mil from Dec. 2012 to Jun. 2013 .

Bodisen Biotech's change in receivables for the fiscal year that ended in Dec. 2012 was £-0.01 Mil. It means Bodisen Biotech's Accounts Receivable increased by £0.01 Mil from Dec. 2011 to Dec. 2012 .

Bodisen Biotech's Accounts Receivable for the quarter that ended in Jun. 2013 was £1.10 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Bodisen Biotech's Days Sales Outstanding for the three months ended in Jun. 2013 was 228.13.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Bodisen Biotech's liquidation value for the three months ended in Jun. 2013 was £0.71 Mil.

Bodisen Biotech Change In Receivables Historical Data

The historical data trend for Bodisen Biotech's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bodisen Biotech Change In Receivables Chart

Bodisen Biotech Annual Data

Trend

Dec03

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Change In Receivables

Get a 7-Day Free Trial

0.39

0.63

-2.43

0.05

-0.01

Bodisen Biotech Quarterly Data
	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Jun13
Change In Receivables	Get a 7-Day Free Trial															1.24	0.28	-1.44	-0.05	0.26

Bodisen Biotech Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2013 adds up the quarterly data reported by the company within the most recent 12 months, which was £-1.23 Mil.

Bodisen Biotech (LSE:BODI) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Bodisen Biotech's Days Sales Outstanding for the quarter that ended in Jun. 2013 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	1.1	/	0.44	*	91
=	228.13

2. In Ben Graham's calculation of liquidation value, Bodisen Biotech's accounts receivable are only considered to be worth 75% of book value:

Bodisen Biotech's liquidation value for the quarter that ended in Jun. 2013 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.096	-	0.697	+	0.75 * 1.1	+	0.5 * 0.972
=	0.71

Bodisen Biotech Change In Receivables Related Terms

Thank you for viewing the detailed overview of Bodisen Biotech's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.